Join The Community

Summary

The product HCG (Human Chorionic Gonadotropin), from an unknown manufacturer, underwent independent testing to verify its authenticity and potency. The sample, associated with Task Number #51800, was submitted by asteroidbiotech@proton.me and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control.

The analysis confirmed the presence of HCG, with a measured concentration of 5152 IU.

The testing process began on 16 October 2024, with the sample received on 31 October 2024, and analysis completed on 4 November 2024. While the results confirm the presence of HCG, manufacturer-submitted samples should always be evaluated critically. Independent third-party testing remains crucial for ensuring consistent quality across batches.

Detailed Report

Product Overview

Testing Details

Testing Results

Verification Details

Evaluation of Manufacturer-Submitted Testing

This analysis confirms the presence of HCG with a potency of 5152 IU, but further verification is needed. Manufacturer-submitted samples can be selectively chosen to pass testing, which may not accurately represent commercially available batches. Janoshik Analytical is a respected independent testing lab, but further verification through third-party analysis is always recommended.

Conclusion

The analysis confirms that HCG contains 5152 IU of the active ingredient, as tested via immunoassay. While the results are promising, further independent testing across different batches is necessary to ensure consistency. This report is published to support educational and harm reduction efforts, helping consumers make informed decisions regarding pharmaceutical products.

Disclaimer

This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.